C4b-binding protein in Alzheimer's disease: Binding to Aβ1-42 and to dead cells

Molecular Immunology

Volumn 45, Issue 13, 2008, Pages 3649-3660

  Trouw, Leendert A ^a   Nielsen, Henrietta M ^b   Minthon, Lennart ^a   Londos, Elisabet ^a   Landberg, Göran ^a   Veerhuis, Robert ^c   Janciauskiene, Sabina ^b   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; C4BP; Complement; Dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; COMPLEMENT COMPONENT C4B BINDING PROTEIN;

ADULT; AGED; ALPHA CHAIN; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN PROTECTION; CELL DEATH; CEREBROSPINAL FLUID; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; APOPTOSIS; BRAIN; CASE-CONTROL STUDIES; CELL DEATH; COMPLEMENT C4B-BINDING PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PROTEIN BINDING; SENILE PLAQUES;

EID: 46749123000     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.04.025     Document Type: Article

References (55)

1. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387-403
2. Blennow K., Fredman P., Wallin A., Gottfries C.G., Karlsson I., Langstrom G., Skoog I., Svennerholm L., and Wikkelso C. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur. Neurol. 33 (1993) 129-133
3. Blom A.M. A cluster of positively charged amino acids in the alpha-chain of C4b-binding-protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria. Scand. J. Clin. Lab. Invest. (Suppl.) 233 (2000) 37-49
4. Blom A.M., Kask L., and Dahlbäck B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276 (2001) 27136-27144
5. Blom A.M., Villoutreix B.O., and Dahlbäck B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?. Mol. Immunol. 40 (2004) 1333-1346
6. Braak H., and Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16 (1995) 271-278 (discussion 271-84)
7. Brookmeyer R., Johnson E., Ziegler-Graham K., and Arrighi H.M. Forecasting the global burden of Alzheimers disease. Alzheimer's Demen. 3 (2007) 186-191
8. Cole D.S., Hughes T.R., Gasque P., and Morgan B.P. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 43 12 (2006) 1953-1964
9. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 209 (1983) 847-856
10. Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J., Rozemuller J.M., Veerhuis R., and Williams A. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40 (2002) 232-239
11. Fadok V.A., and Chimini G. The phagocytosis of apoptotic cells. Semin. Immunol. 13 (2001) 365-372
12. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., and Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
13. Fishelson Z., Donin N., Zell S., Schultz S., and Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol. Immunol. 40 (2003) 109-123
14. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
15. Garcia de Frutos P., Alim R.I., Härdig Y., Zoller B., and Dahlbäck B. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 84 (1994) 815-822
16. Garcia de Frutos P., Härdig Y., and Dahlbäck B. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270 (1995) 26950-26955
17. Gardai S.J., Bratton D.L., Ogden C.A., and Henson P.M. Recognition ligands on apoptotic cells: a perspective. J. Leukoc. Biol. 79 (2006) 896-903
18. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., and Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49 (2000) 171-186
19. Gasque P., Ischenko A., Legoedec J., Mauger C., Schouft M.T., and Fontaine M. Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells. J. Biol. Chem. 268 (1993) 25068-25074
20. Jiang H., Burdick D., Glabe C.G., Cotman C.W., and Tenner A.J. Beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the Clq A chain. J. Immunol. 152 (1994) 5050-5059
21. Jones J., and Morgan B.P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 86 (1995) 651-660
22. Kalaria R.N., and Kroon S.N. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem. Biophys. Res. Commun. 186 (1992) 461-466
23. Kalaria R.N., and Perry G. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease. Brain. Res. 631 (1993) 151-155
24. Kask L., Hillarp A., Ramesh B., Dahlbäck B., and Blom A.M. Structural requirements for the intra-cellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 41 (2002) 9349-9357
25. Kask L., Trouw L.A., Dahlbäck B., and Blom A.M. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J. Biol. Chem. 279 (2004) 23869-23873
26. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15 (1966) 45-52
27. McGeer E.G., Klegeris A., and McGeer P.L. Inflammation, the complement system and the diseases of aging. Neurobiol. Aging 26 Suppl. 1 (2005) 94-97
28. McGeer P.L., and McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22 (2001) 799-809
29. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., and Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (2005) 1863-1872
30. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
32. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., and Roos A. Direct binding of Clq to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32 (2002) 1726-1736
33. Nielsen H.M., Londos E., Minthon L., and Janciauskiene S.M. Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol. Dis. 26 (2007) 27-35
34. Nielsen H.M., Minthon L., Londos E., Blennow K., Miranda E., Perez J., Crowther D.C., Lomas D.A., and Janciauskiene S.M. Plasma and CSF serpins in Alzheimer's disease and dementia with Lewy bodies. Neurology 69 (2007) 1569-1579
35. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41 (2004) 355-367
36. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., and van Kooten C. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34 (2004) 921-929
37. Rostagno A., Lashley T., Ng D., Meyerson J., Braendgaard H., Plant G., Bojsen-Moller M., Holton J., Frangione B., Revesz T., and Ghiso J. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease. J. Neurol. Sci. 257 (2007) 88-96
38. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
39. Sjöberg A.P., Trouw L.A., McGrath F.D., Hack C.E., and Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein. J. Immunol. 176 (2006) 7612-7620
40. Snyder S., Wang G.T., Barrett L., Ladror U.S., Casuto D., Lee C.M., Krafft G.A., Holzman R.B., and Holzman T.F. Complement Clq does not bind monomeric beta-amyloid. Exp. Neurol. 128 (1994) 136-142
41. Tenner A.J., and Fonseca M.I. The double-edged flower: roles of complement protein Clq in neurodegenerative diseases. Adv. Exp. Med. Biol. 586 (2006) 153-176
42. Thomas A., Gasque P., Vaudry D., Gonzalez B., and Fontaine M. Expression of a complete and functional complement system by human neuronal cells in vitro. Int. Immunol. 12 (2000) 1015-1023
43. Trouw L.A., Bengtsson A.A., Gelderman K.A., Dahlbäck B., Sturfelt G., and Blom A.M. C4b-binding protein and factor H compensate for the loss of membrane bound complement inhibitors to protect against excessive complement attack. J. Biol. Chem. 282 (2007) 28540-28548
44. Trouw L.A., Nilsson S.C., Goncalves I., Landberg G., and Blom A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201 (2005) 1937-1948
45. Van Schravendijk M.R., and Dwek R.A. Interaction of Clq with DNA. Mol. Immunol. 19 (1982) 1179-1187
46. Veerhuis R., Boshuizen R.S., and Familian A. Amyloid associated proteins in Alzheimer's and prion disease. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 235-248
47. Veerhuis R., Janssen I., De Groot C.J., Van Muiswinkel F.L., Hack C.E., and Eikelenboom P. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not Cl-inhibitor. Exp. Neurol. 160 (1999) 289-299
48. Veerhuis R., Janssen I., Hack C.E., and Eikelenboom P. Early complement components in Alzheimer's disease brains. Acta Neuropathol. (Berl.) 91 (1996) 53-60
49. Veerhuis R., van der Valk P., Janssen I., Zhan S.S., Van Nostrand W.E., and Eikelenboom P. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3. Virchows Arch. 426 (1995) 603-610
50. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
51. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
52. Webb J.H., Blom A.M., and Dahlbäck B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J. Immunol. 169 (2002) 2580-2586
53. Webb J.H., Blom A.M., and Dahlbäck B. The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis-dependent. Blood Coagul. Fibrinolysis 14 (2003) 355-359
54. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-a double edged sword. Neuron 35 (2002) 419-432
55. Zhan S.S., Veerhuis R., Kamphorst W., and Eikelenboom P. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 4 (1995) 291-297